TIX100
Asset
Investigational oral therapeutic for overweight and obesity.
- Stage
- Phase 1
- Modality
- Small molecule
- Target
- Lipid and ceramide metabolism
- 2
- Indications
- 1
- Trial
- 1
- Developer
Indications
2Health adult subjects
Phase 1, Recruiting, NCT07675590, clinicaltrials.gov, 7 Oct 2026
Obesity & overweight
Phase 1, Recruiting, NCT07675590, clinicaltrials.gov, 7 Oct 2026
In the full profile
- Targets and what it contains1
- Owner and partners1
- Trials1
- Evidence for its targets1
- Competitors7
- Aging relevance1
- Signals2
Every asset’s record: target, stage, trials and the evidence behind it.